Home » Topics » BioWorld Science

BioWorld Science
RSS

Sareum Holdings identifies TYK2 inhibitors

May 4, 2020

Janssen BioPharma presents new antivirals

May 4, 2020

Tumor burden reduction seen with Pexa-Vec vaccine in phase I renal cell carcinoma trial

May 4, 2020

Thwarting the hijacker: in vitro study gives "blueprint", drug leads for SARS-CoV-2

May 4, 2020

Terns patents new THR-beta agonists

May 4, 2020

Novartis presents preclinical data for TNO-155

May 4, 2020

Discovery of a novel highly potent and orally active EED inhibitor

May 4, 2020

SIAIS-117, novel ALK degrader as potential therapy for ALK-positive cancer types

May 4, 2020

Mesoblast initiates phase II/III study of remestemcel-L in patients with COVID-19 ARDS

May 4, 2020

Pancreatic cancer uses autophagy to hide from immune system

May 4, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...